Nanoplasmonics Enhanced Laser Gene Delivery for Retinal Degenerative Diseases

纳米等离子体增强激光基因传递治疗视网膜退行性疾病

• 批准号: 269856
• 负责人: Meunier Michel
• 金额: $ 19.6万
• 依托单位: Polytechnique Montral
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-10-01 至 2015-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=269856&lang=en
• 关键词: 1101 Human Health; 1102 Biomedical Engineering; 1901 Biomedical Technology; Age-Related Macular Degeneration; Cell Transfection; Glaucoma; Laser Therapy; Plasmonic Nanoparticles; Retinitis Pigmentosa; Retinotherapy

Retinal degenerative diseases are the leading causes of vision loss and affect millions of individuals in Canada. These diseases are either incurable or can be only moderately ameliorated with current therapies. As an emerging solution, delivering therape

视网膜退行性疾病是视力丧失的主要原因，影响加拿大数百万人。这些疾病要么是无法治愈的，要么只能用目前的疗法适度改善。作为一种新兴的解决方案，